+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mundipharma International Ltd. - logo

MundiPharma is an Irish owned company established in 1973. There break through drug was sustained release morphine (MST® Continus® tablets). This product was seen as a major advantage in handling cancer treatment pain. MundiPharma focus on three main areas: analgesic, oncology and respiratory therapy areas. They are constantly innovating new products to help people with debilitating diseases. Mundi Pharma is part of a worldwide network of independent associated pharmaceutical companies.

From
Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Pain Management Drugs Market Report 2025 - Product Thumbnail Image

Pain Management Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Advanced Endometrial Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Licensing Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 1400 Pages
  • Global
From
From
Transdermal Drug Patches to 2028 - Product Thumbnail Image

Transdermal Drug Patches to 2028

  • Report
  • October 2021
  • 185 Pages
  • Global
From
Loading Indicator